A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses

Drug-Resistant and Genetic Evolutionary Analysis of Influenza Virus from Patients During the 2013 and 2014 Influenza Season in Beijing

(2017) Xiaodong Li et al.   Microbial Drug Resistance

A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action

(2017) Ning Chai et al.   Nature Communications

Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes

(2016) Nicole L. Kallewaard et al.   CELL

Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact

(2016) Paul E. Leon et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids

(2016) Freek Cox et al.   Frontiers in Immunology

Epidemiological and Phylogenetic Characteristics of Influenza B Infection in Severe Acute Respiratory Infection Cases in Beijing, 2014 to 2015

(2015) Yang Pan et al.   MEDICINE

Advances in the development of influenza virus vaccines

(2015) Florian Krammer et al.   NATURE REVIEWS DRUG DISCOVERY

Immune history profoundly affects broadly protective B cell responses to influenza

(2015) Sarah F. Andrews et al.   Science Translational Medicine

Influenza virus antigenicity and broadly neutralizing epitopes

(2015) Gillian M Air   Current Opinion in Virology

Molecular Epidemiology and Phylogenetic Analyses of Influenza B Virus in Thailand during 2010 to 2014

(2015) Nipaporn Tewawong et al.   PLoS One

Impact of Influenza B Lineage-Level Mismatch Between Trivalent Seasonal Influenza Vaccines and Circulating Viruses, 1999–2012

(2014) Terho Heikkinen et al.   CLINICAL INFECTIOUS DISEASES

Comparing Clinical Characteristics Between Hospitalized Adults With Laboratory-Confirmed Influenza A and B Virus Infection

(2014) S. Su et al.   CLINICAL INFECTIOUS DISEASES

Intranasal Vaccination Promotes Detrimental Th17-Mediated Immunity against Influenza Infection

(2014) Asher Maroof et al.   PLoS Pathogens

The specificity of the influenza B virus hemagglutinin receptor binding pocket: what does it bind to?

(2013) Tony Velkov   JOURNAL OF MOLECULAR RECOGNITION

Identification of Dominant Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Antigen of Pandemic H1N1 Influenza Virus

(2013) V. Srivastava et al.   JOURNAL OF VIROLOGY

The prospects and challenges of universal vaccines for influenza

(2013) Kanta Subbarao et al.   TRENDS IN MICROBIOLOGY

Human Monoclonal Antibodies Broadly Neutralizing against Influenza B Virus

(2013) Mayo Yasugi et al.   PLoS Pathogens

Mucosal immunity and nasal influenza vaccination

(2012) Markus A Rose et al.   Expert Review of Vaccines

Cross-Lineage Influenza B and Heterologous Influenza A Antibody Responses in Vaccinated Mice: Immunologic Interactions and B/Yamagata Dominance

(2012) Danuta M. Skowronski et al.   PLoS One

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells

(2012) G.-M. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Highly Conserved Protective Epitopes on Influenza B Viruses

(2012) C. Dreyfus et al.   SCIENCE

Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses

(2012) D. R. Burton et al.   SCIENCE

Elicitation of Broadly Neutralizing Influenza Antibodies in Animals with Previous Influenza Exposure

(2012) C.-J. Wei et al.   Science Translational Medicine

Antibody Pressure by a Human Monoclonal Antibody Targeting the 2009 Pandemic H1N1 Virus Hemagglutinin Drives the Emergence of a Virus with Increased Virulence in Mice

(2012) C. D. O'Donnell et al.   mBio

A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins

(2011) D. Corti et al.   SCIENCE

The need for quadrivalent vaccine against seasonal influenza

(2010) Robert B. Belshe   VACCINE